GlassScriptPhysician profile
Bianca Kenyon
NPI 1609293836
$3,763.26
in general payments reported to CMS, 2019-2025
17 companies · $1,483 in 2025
The $1,483 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $115 · 2021: $1,538 · 2022: $208 · 2023: $66.56 · 2025: $1,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,417.03 | 2021-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Abbott Laboratories | $388.44 | 2025 | Diamondback Peripheral, Esprit |
| Tela Bio, INC. | $341.80 | 2019-2020 | |
| Medtronic, INC. | $314.37 | 2021-2025 | Hawkone |
| Endologix LLC | $303.18 | 2025 | Alto Abdominal Stent Graft System |
| Silk Road Medical, INC. | $176.40 | 2021-2022 | |
| Acell, INC. | $125.45 | 2019 | |
| Lilly USA, LLC | $124.51 | 2025 | |
| Ionis Pharmaceuticals, INC. | $122.03 | 2025 | Tryngolza |
| Novo Nordisk INC | $118.99 | 2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $118.98 | 2025 | |
| Boston Scientific Corporation | $113.07 | 2025 | Enroute Transcarotid Neuroprotection System |
| Recor Medical INC | $28.00 | 2025 | Paradise Ultrasound Renal Denervation System |
| Pfizer INC. | $21.83 | 2025 | |
| Cvrx, INC. | $19.15 | 2025 | Barostim Neo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $15.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Kenyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.